What are the recommended maximum doses of bupivacaine for adults (with and without epinephrine) for different administration routes such as local infiltration, peripheral nerve block, epidural analgesia, and spinal anesthesia?

Bupivacaine Maximum Dosing for Adults

For adult patients, use a maximum dose of 175 mg (2.5 mg/kg) of bupivacaine when combined with epinephrine, or 150 mg (2 mg/kg) without epinephrine, regardless of administration route.

Maximum Dose Guidelines

The FDA-approved labeling and established clinical practice support the following maximum doses for bupivacaine 1:

With Epinephrine (1:200,000)

• 175 mg total dose (approximately 2.5 mg/kg for a 70 kg adult)
• This applies to all routes: local infiltration, peripheral nerve blocks, and epidural administration

Without Epinephrine

• 150 mg total dose (approximately 2 mg/kg for a 70 kg adult)
• Lower dose required due to faster systemic absorption without vasoconstriction

Route-Specific Concentrations

The FDA label specifies approved concentrations by route 1:

• Local infiltration: 0.25%
• Peripheral nerve blocks: 0.25% or 0.5%
• Retrobulbar block: 0.75%
• Sympathetic block: 0.25%
• Lumbar epidural: 0.25%, 0.5%, or 0.75% (0.75% contraindicated in obstetrics)
• Caudal: 0.25% or 0.5%
• Dental blocks: 0.5% with epinephrine 1:200,000

Critical Safety Considerations

The maximum dose is NOT higher for epidural or spinal routes. A common pitfall is assuming neuraxial administration allows higher doses—this is incorrect and dangerous. The same 175 mg (with epi) or 150 mg (without epi) maximum applies 2.

Epinephrine's role: Adding epinephrine 1:200,000 allows a 25 mg dose increase (from 150 to 175 mg) by slowing systemic absorption through vasoconstriction. However, if inadvertent intravascular injection occurs, epinephrine-containing solutions have increased toxicity 2.

Volume Calculations

For practical dosing:

• 0.25% bupivacaine = 2.5 mg/mL

  • Maximum volume with epi: 70 mL (175 mg)
  • Maximum volume without epi: 60 mL (150 mg)

• 0.5% bupivacaine = 5 mg/mL

  • Maximum volume with epi: 35 mL (175 mg)
  • Maximum volume without epi: 30 mL (150 mg)

• 0.75% bupivacaine = 7.5 mg/mL

  • Maximum volume with epi: 23 mL (175 mg)
  • Maximum volume without epi: 20 mL (150 mg)

Special Circumstances

Incremental dosing over time: One study demonstrated safety with 500 mg lidocaine delivered incrementally over 8 hours during Mohs surgery, but no equivalent data exists for bupivacaine 3. Exercise extreme caution with repeated dosing—cumulative toxicity remains a risk.

Low-volume ultrasound-guided blocks: Modern ultrasound guidance allows effective blocks with volumes as low as 5-6 mL of 0.5% bupivacaine (25-30 mg), well below maximum doses 4, 5. This minimizes systemic exposure and adverse effects like phrenic nerve paralysis.

Toxicity Recognition

Local anesthetic systemic toxicity (LAST) progresses predictably 3:

1. Early CNS signs: Circumoral numbness, metallic taste, tinnitus, slurred speech
2. Progression: Seizures, CNS depression
3. Severe: Cardiac arrhythmias, cardiovascular collapse

Monitor all patients receiving doses approaching maximum limits. Have lipid emulsion rescue therapy immediately available for any regional anesthetic procedure.